A total of 89.8 % of the Cuban population has already completed the vaccination program against COVID-19, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.
The health system in the province of Holguín maintains the control measures of COVID-19 for the protection of vulnerable sectors, even when the eastern territory reduces the incidence rates of the disease, declared a pandemic by the World Health Organization.
With the purpose of perpetuating the role of family medicine in the support of Primary Health Care (PHC), the municipality of Gibara, in Holguín, sponsors the first international virtual conference on this medical specialty “APSGibara2022”.
The British group The Lancet Discovery Science published a scientific article on the anti-Covid-19 Abdala vaccine, which shows that it is safe, well-tolerated, and induces a potent immune response against SARS-CoV-2; it was reported Monday.